Medicinova, Inc. (MNOV) is a publicly traded Healthcare sector company. As of September 18, 2026, MNOV trades at $3.56 with a market cap of $124.04M and a P/E ratio of -16.21. MNOV moved -1.01% today. Year to date, MNOV is +159.40%; over the trailing twelve months it is +182.79%. Its 52-week range spans $1.13 to $3.90. Analyst consensus is moderatebuy with an average price target of $8.00. Rallies surfaces MNOV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
2 analysts cover MNOV: 0 strong buy, 2 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is moderatebuy. The average price target is $8.00.
| Metric | Value |
|---|---|
| Price | $3.56 |
| Market Cap | $124.04M |
| P/E Ratio | -16.21 |
| EPS | $-0.21 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.90 |
| 52-Week Low | $1.13 |
| Volume | 892.77K |
| Avg Volume | 0 |
| Revenue (TTM) | $920.48K |
| Net Income | $-10.75M |
| Gross Margin | 0.00% |
2 analysts cover MNOV: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is moderatebuy. Average price target: $8.00.